文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

合并常见疾病的早产儿的营养管理:一项叙述性综述

Nutritional Management for Preterm Infants with Common Comorbidities: A Narrative Review.

作者信息

Chen Cheng-Yen, Lai Mei-Yin, Lee Cheng-Han, Chiang Ming-Chou

机构信息

Division of Neonatology, Department of Pediatrics, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan 33305, Taiwan.

Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taoyuan 33305, Taiwan.

出版信息

Nutrients. 2025 Jun 9;17(12):1959. doi: 10.3390/nu17121959.


DOI:10.3390/nu17121959
PMID:40573070
Abstract

The complications observed in preterm infants are largely attributable to underdeveloped organ systems and inadequate nutritional stores at birth. Insufficient nutritional support can further exacerbate persistent sequelae, such as bronchopulmonary dysplasia (BPD), metabolic bone disease of prematurity (MBDP), and retinopathy of prematurity (ROP). As a result, clinicians have collaborated to develop optimal nutrition strategies for preterm neonates. However, these clinical nutrition plans may be hindered by several factors, including fluid restrictions due to patent ductus arteriosus (PDA) and delayed enteral nutrition following necrotizing enterocolitis (NEC). Modified strategies for specific conditions can help prevent further deterioration, but inadequate nutritional support may limit organ growth and contribute to additional complications. Achieving an optimal balance between nutritional support and managing specific medical conditions varies across institutions. In addition to fluid balance and energy intake, supplementary nutrition-such as vitamins and probiotics-plays a crucial role in disease prevention. Drawing on recent evidence and our clinical experiences with neonatal nutritional strategies, this review article summarizes the specialized nutritional management required for preterm neonates with conditions such as BPD, NEC, MBDP, PDA, and ROP.

摘要

早产儿出现的并发症很大程度上归因于出生时器官系统发育不全和营养储备不足。营养支持不足会进一步加重持续性后遗症,如支气管肺发育不良(BPD)、早产儿代谢性骨病(MBDP)和早产儿视网膜病变(ROP)。因此,临床医生共同制定了针对早产新生儿的最佳营养策略。然而,这些临床营养计划可能会受到多种因素的阻碍,包括动脉导管未闭(PDA)导致的液体限制以及坏死性小肠结肠炎(NEC)后的肠内营养延迟。针对特定情况的改良策略有助于防止病情进一步恶化,但营养支持不足可能会限制器官生长并导致更多并发症。在不同机构中,实现营养支持与管理特定医疗状况之间的最佳平衡各不相同。除了液体平衡和能量摄入外,补充营养物质(如维生素和益生菌)在疾病预防中起着至关重要的作用。基于最近的证据以及我们在新生儿营养策略方面的临床经验,本文综述总结了患有BPD、NEC、MBDP、PDA和ROP等疾病的早产新生儿所需的特殊营养管理方法。

相似文献

[1]
Nutritional Management for Preterm Infants with Common Comorbidities: A Narrative Review.

Nutrients. 2025-6-9

[2]
Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.

Cochrane Database Syst Rev. 2025-6-23

[3]
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.

Cochrane Database Syst Rev. 2008-1-23

[4]
Higher versus lower amino acid intake in parenteral nutrition for newborn infants.

Cochrane Database Syst Rev. 2018-3-5

[5]
Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.

Cochrane Database Syst Rev. 2007-4-18

[6]
Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.

Cochrane Database Syst Rev. 2017-8-30

[7]
Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.

Cochrane Database Syst Rev. 2003

[8]
Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.

Cochrane Database Syst Rev. 2017-6-28

[9]
Automated oxygen delivery for preterm infants with respiratory dysfunction.

Cochrane Database Syst Rev. 2023-11-30

[10]
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.

Cochrane Database Syst Rev. 2005-10-19

本文引用的文献

[1]
Association of Neonatal Morbidities and Postnatal Growth Faltering in Preterm Neonates.

Healthcare (Basel). 2025-1-24

[2]
Fluid restriction for treatment of symptomatic patent ductus arteriosus in preterm infants.

Cochrane Database Syst Rev. 2024-12-18

[3]
Effects of synbiotics on necrotizing enterocolitis and full enteral feeding in very low birth weight infants: A double-blind, randomized controlled trial.

Medicine (Baltimore). 2024-9-13

[4]
Oral DHA supplementation and retinopathy of prematurity: the Joinville DHA Clinical Trial.

Br J Nutr. 2024-8-14

[5]
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.

Lancet Respir Med. 2024-7

[6]
Breast-feeding as protective factor against bronchopulmonary dysplasia in preterm infants.

Br J Nutr. 2024-4-28

[7]
The Effects of Early Enteral and Parental Nutrition on Retinopathy of Prematurity: A Systematic Review.

Cureus. 2023-11-18

[8]
Guidelines for parenteral nutrition in preterm infants: The American Society for Parenteral and Enteral Nutrition.

JPEN J Parenter Enteral Nutr. 2023-9

[9]
Prognostic Value of Parenteral Nutrition Duration on Risk of Retinopathy of Prematurity: Development and Validation of the Revised DIGIROP Clinical Decision Support Tool.

JAMA Ophthalmol. 2023-8-1

[10]
The imperative of arachidonic acid in early human development.

Prog Lipid Res. 2023-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索